evolocumab
amgen
['fourier', 'evolocumab']
total event analysis from #fourier shows doubling of events prevented with early #evolocumab #acc23 
Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.